logo

For the Inventor, By the Inventor

Kyoto, Japan

Kyoto Pharmaceutical Industries, Ltd.

Calculating rank
USPTO Granted Patents = 26

% Expired Patents = 30.8



Forward Citations = 109

Loading Chart...
Loading Chart...

54 inventors (with patents filed for the assignee):

goldMedal Hiroaki Shirahase (13 out of 16 patents)

silverMedal Masayasu Kasai (10 out of 11 patents)

bronzeMedal Hiroshi Matsui (10 out of 14 patents)

4.  Akihisa Yoshimi (8 out of 8 patents)

5.  Shohei Nakamura (6 out of 11 patents)

6.  Yoshimichi Shoji (5 out of 6 patents)

7.  Shigemitsu Takeda (5 out of 6 patents)

8.  Nobuharu Kakeya (5 out of 6 patents)

9.  Shoji Kamiya (4 out of 8 patents)

10.  Susumu Nishizawa (4 out of 4 patents)

11.  Kazuhiko Kitao (4 out of 7 patents)

12.  Yoshinobu Yoshimura (3 out of 4 patents)

13.  Hideo Kobayashi (3 out of 3 patents)

14.  Satoru Azukizawa (3 out of 3 patents)

15.  Katsuo Wada (3 out of 6 patents)


Core Competencies:
Benzotriazole Compound
Anticancer Agent
Cyclin-Dependent Kinase Inhibitor
Insulin Resistance
Heterocyclic Compound
Indoline Compound
Cromoglycic Acid
Carbapenem Derivatives
Cephalosporin Compounds
Therapeutic Agent
Antirheumatic Agent
1,4-Dihydropyridine Derivatives

26 patents:

1. 12378260 - Benzotriazole compound (2025-08-05),
2. 11267797 - Anticancer agent (2022-03-08),
3. 11013728 - Cyclin-dependent kinase 8 and/or 19 inhibitor (2021-05-25),
4. 10377730 - Anticancer agent (2019-08-13),
5. 10059663 - Aromatic compound and use thereof (2018-08-28),
6. 10005752 - Anticancer agent (2018-06-26),
7. 7718377 - Insulin resistance curative and method of screening the same (2010-05-18),
8. 7557123 - Heterocyclic compound and medicinal use thereof (2009-07-07),
9. 7429612 - Indoline compound and medicinal use thereof (2008-09-30),
10. RE38970 - Indolyl or indolinyl derivatives and medicinal use thereof as ACAT or lipid peroxidation inhibitors (2006-02-06),
11. 6872732 - Heterocyclic derivatives and medicinal use thereof (2005-03-29),
12. 6589963 - Heterocyclic compounds and salts thereof and medicinal use of the same (2003-07-08),
13. 6410525 - Carbapenem derivatives, utilization thereof and intermediate compounds of the same (2002-06-25),
14. 6342494 - Carbapenem compounds, use thereof, and intermediate compounds of the same (2002-01-29),
15. 6262108 - Medicinal use of cromoglycic acid compounds (2001-07-17),
Company Overview
Kyoto Pharmaceutical Industries, Ltd. is a prominent player in the pharmaceutical sector, specializing in the development and manufacturing of innovative therapeutic solutions. The company focuses on various domains, including drug formulation and delivery systems, with a commitment to enhancing patient care through advanced medical technologies. Based in Kyoto, Japan, the organization leverages its expertise to contribute to the global healthcare landscape, emphasizing research-driven approaches to address unmet medical needs.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

26 Patents

#81 in Kyoto 615-0031

#2,509 in Japan

#24,848 in the World

Kyoto, JP
Kyoto, Japan

Kyoto Pharmaceutical Industries, Ltd.

Forward Citations = 109

54 inventors:

goldMedal Hiroaki Shirahase (13 out of 16 patents)

silverMedal Masayasu Kasai (10 out of 11 patents)

bronzeMedal Hiroshi Matsui (10 out of 14 patents)

4.  Akihisa Yoshimi (8 out of 8 patents)

5.  Shohei Nakamura (6 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kyoto Pharmaceutical Industries, Ltd.. Retrieved from https://idiyas.com/company/kyoto-pharmaceutical-industries

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…